ZNF526 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.080200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.612600E-01
Normal-vs-Stage2
7.977000E-01
Normal-vs-Stage3
4.053000E-01
Normal-vs-Stage4
4.201200E-01
Stage1-vs-Stage2
4.955000E-01
Stage1-vs-Stage3
8.035600E-02
Stage1-vs-Stage4
8.297200E-01
Stage2-vs-Stage3
9.743900E-02
Stage2-vs-Stage4
4.466200E-01
Stage3-vs-Stage4
1.466180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.626000E-01
Normal-vs-AfricanAmerican
6.812400E-01
Normal-vs-Asian
3.140400E-01
Caucasian-vs-AfricanAmerican
7.861200E-01
Caucasian-vs-Asian
1.108200E-01
AfricanAmerican-vs-Asian
3.879200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.282400E-01
Normal-vs-Female
7.961200E-01
Male-vs-Female
8.473000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.723800E-01
Normal-vs-Age(41-60Yrs)
5.377600E-01
Normal-vs-Age(61-80Yrs)
9.213400E-01
Normal-vs-Age(81-100Yrs)
6.616800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.399000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.640000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.446050E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.043950E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.509500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.227800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.206200E-01
Normal-vs-Daily Drinker
7.718600E-01
Normal-vs-Weekly Drinker
5.959000E-01
Normal-vs-Occasional Drinker
4.810000E-01
Normal-vs-Social Drinker
8.699200E-01
Non Drinker-vs-Daily Drinker
1.737560E-01
Non Drinker-vs-Weekly Drinker
9.737900E-02
Non Drinker-vs-Occasional Drinker
3.295800E-02
Non Drinker-vs-Social Drinker
3.268800E-01
Daily Drinker-vs-Weekly Drinker
7.272800E-01
Daily Drinker-vs-Occasional Drinker
4.856800E-01
Daily Drinker-vs-Social Drinker
6.413600E-01
Weekly Drinker-vs-Occasional Drinker
7.563200E-01
Weekly Drinker-vs-Social Drinker
3.877400E-01
Occasional Drinker-vs-Social Drinker
2.153400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.611000E-01
Normal-vs-Grade 2
5.746800E-01
Normal-vs-Grade 3
5.353400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.017700E-02
Grade 1-vs-Grade 3
2.992100E-02
Grade 1-vs-Grade 4
2.611000E-01
Grade 2-vs-Grade 3
2.759400E-01
Grade 2-vs-Grade 4
5.746800E-01
Grade 3-vs-Grade 4
5.353400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.590400E-01
Normal-vs-NonDiabetic
6.365800E-01
Diabetic-vs-NonDiabetic
4.658500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.904400E-01
Normal-vs-NoPancreatitis
8.332200E-01
Pancreatitis-vs-NoPancreatitis
4.650600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.046400E-01
Normal-vs-N1
8.311800E-01
N0-vs-N1
8.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.660800E-01
Normal-vs-TP53-NonMutant
8.033800E-01
TP53-Mutant-vs-TP53-NonMutant
6.398400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
